These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18700558)

  • 1. [Blood pressure lowering therapy for mild hypertensive patients with a history of stroke].
    Ishikawa E; Ibayashi S
    Nihon Rinsho; 2008 Aug; 66(8):1560-5. PubMed ID: 18700558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood pressure control in chronic stroke].
    Nagai M; Hoshide S; Kario K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():378-83. PubMed ID: 16981568
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrovascular disease and diabetic patients with hypertension].
    Kawamura T
    Nihon Rinsho; 2003 Jul; 61(7):1175-80. PubMed ID: 12877081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and secondary prevention of stroke by antihypertensive drug treatment.
    Wang JG; Li Y
    Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
    Piechowski-Jóźwiak B; Bogousslavsky J
    Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
    Papadopoulos DP; Papademetriou V
    J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension in the acute phase and in the secondary prevention of stroke].
    Arquizan C
    Rev Prat; 2004 Mar; 54(6):637-40. PubMed ID: 15222615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intervention trials for elderly hypertension in Western countries].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2005 Jun; 63(6):1071-7. PubMed ID: 15948393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of hypertension in elderly patients with stroke].
    Bokura H; Kobayashi S
    Nihon Rinsho; 2005 Jun; 63(6):1029-32. PubMed ID: 15948386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
    Dowlatshahi D; Hill MD
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):771-5. PubMed ID: 15350178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.